These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11244765)

  • 1. [Clinical evaluation of roxatidine acetate hydrochlorides as a preanesthetic medication].
    Namba M; Chihara E; Ibuki T; Ashida H; Fukushima H; Tanaka Y
    Masui; 2001 Feb; 50(2):127-35. PubMed ID: 11244765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors.
    Hirota K; Imai A; Kudo M; Hashimoto H; Kushikata T
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1244-7. PubMed ID: 19486452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of oral administration of roxatidine acetate hydrochloride 3 hours prior to the operation on pH and volume of gastric juice].
    Kojima A; Andoh K; Shima T; Koga Y; Hashimoto Y
    Masui; 1991 Mar; 40(3):451-3. PubMed ID: 1677048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of roxatidine acetate hydrochloride injection as preanesthetic medication].
    Kawanishi M; Enomoto A; Shimada Y; Kurokawa Y
    Masui; 1991 Sep; 40(9):1364-70. PubMed ID: 1682516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of roxatidine acetate in fasting patients prior to induction of anaesthesia as prophylaxis against the acid aspiration syndrome.
    Tryba M; Wruck G; Thole H; Zenz M
    Drugs; 1988; 35 Suppl 3():20-4. PubMed ID: 2905245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combined use of roxatidine and pirenzepine on gastric secretion in humans.
    Misawa T; Chijiiwa Y; Yoshida K; Tanaka A; Kabemura T; Fujishima H; Harada N; Nawata H
    Fukuoka Igaku Zasshi; 1990 Jul; 81(7):242-6. PubMed ID: 1976580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic assessment of nocturnal gastric juice secretion after administration of roxatidine acetate hydrochloride.
    Tanioka H; Terahara A; Sasaki Y
    Clin Ther; 1991; 13(1):22-4. PubMed ID: 1674230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
    Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
    Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.
    Hirota K; Kudo M; Hashimoto H; Kushikata T
    Anesth Analg; 2005 Oct; 101(4):1038-1041. PubMed ID: 16192516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular use of H2 blockers reduces the efficacy of roxatidine to control gastric pH and volume.
    Hirota K; Kudo M; Kushikata T; Hashimoto H; Matsuki A
    Can J Anaesth; 2005 Feb; 52(2):166-71. PubMed ID: 15684257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of roxatidine acetate for handicapped patients under general anesthesia.
    Kitagawa E; Kubota M; Kaekura N; Fujisawa T; Fukushima K
    Anesth Prog; 1989; 36(4-5):169-71. PubMed ID: 2577386
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
    Gladziwa U; Wagner S; Sieberth HG; Klotz U
    Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of roxatidine acetate on daytime and night-time peptone-stimulated gastric acid secretion.
    Hagenmüller F
    Drugs; 1988; 35 Suppl 3():65-8. PubMed ID: 2905251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?
    Hashimoto H; Kushikata T; Kudo M; Hirota K
    J Gastroenterol; 2007 Apr; 42(4):275-8. PubMed ID: 17464455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
    Hemery P; Congard P; Galmiche JP; Bonfils S
    Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
    Merki HS; Bender W; Labs R
    J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
    Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the animal pharmacology of roxatidine acetate.
    Scholtholt J; Bickel M; Herling AW
    Drugs; 1988; 35 Suppl 3():30-40. PubMed ID: 2905247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ranitidine in the premedication of anaesthesia--double-blind comparative study with placebo].
    Noguchi J; Kawazoe T; Yamamura H; Takahashi T; Namiki A; Amaha K; Koga Y; Takahashi S; Usui K; Inada Y
    Masui; 1985 Jan; 34(1):71-81. PubMed ID: 2860259
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect].
    Chen WW; Kolsky H; Lewin MJ; Bonfils S
    Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.